Financhill
Back

Verrica Pharmaceuticals 10K Form

Sell
17

VRCA
Verrica Pharmaceuticals

Last Price:
0.72
Seasonality Move:
31.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive VRCA News And Ratings

See the #1 stock for the next 7 days that we like better than VRCA

VRCA Financial Statistics

Sales & Book Value

Annual Sales: $5.12M
Cash Flow: $-8.57M
Price / Cash Flow: 0
Annual Sales: $-0.80
Price / Book: 0

Profitability

EPS (TTM): -1.84000
Net Income (TTM): $-84.99M
Gross Margin: $4.38M
Return on Equity: -2619.46%
Return on Assets: -128.78%

Verrica Pharmaceuticals Earnings Forecast

Key Verrica Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 3 years for VRCA is 85.44%.
  • The Selling, General & Administrative Expenses for VRCA have been equal to 923.20% of Gross Profit Margin.
  • The Research & Development expenses have been 396.08% of Revenue.
  • The Interest Expense is -5.91% of Operating Income.
  • The Net Earning history of VRCA is -1,307.47% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

Verrica Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: VRCA
CUSIP: 92511W
Website: verrica.com

Debt

Debt-to-Equity Ratio: -1.27
Current Ratio: 1.34
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VRCA Technical Analysis vs Fundamental Analysis

Sell
17
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy or a Sell?